Vita Coco (COCO) director reports 50,000-share sale under 10b5-1

Rhea-AI Filing Summary

Insider sale under a Rule 10b5-1 plan: Liran Ira, a director of Vita Coco Company, Inc. (COCO), reported selling 50,000 shares of the issuer's common stock on 09/17/2025 at a weighted average price of $42.003 per share. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan. After the reported transactions, the form discloses 598,341 shares held directly and 692,579 shares held indirectly through the Ira Liran 2012 Family Trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.

Positive

• Sale executed under a Rule 10b5-1 plan, indicating pre-established trading instructions and procedural compliance
• Significant insider ownership remains: 598,341 shares directly and 692,579 shares indirectly via the Ira Liran 2012 Family Trust

Negative

• Director disposed of 50,000 shares, which is an outright sale of insider holdings

Insights

Securities Analyst

TL;DR: Director sold 50,000 COCO shares via a Rule 10b5-1 plan; substantial remaining holdings remain both direct and indirect.

The reported sale of 50,000 shares at a weighted average price of $42.003 was executed under a pre-established Rule 10b5-1 trading plan, which indicates the transactions were pre-planned rather than opportunistic. The reporting person continues to hold material positions: 598,341 shares directly and 692,579 shares indirectly via a family trust, which together represent meaningful insider ownership that remains after the disposition.

Corporate Governance Expert

TL;DR: Use of 10b5-1 plan provides procedural compliance; filing shows preserved insider ownership post-sale.

The Form 4 documents compliance with Section 16 reporting and notes that the sale was made pursuant to a Rule 10b5-1 plan, a common mechanism to provide affirmative defense against insider trading claims. The continued direct and indirect holdings reported suggest the director retains a significant economic interest in the company despite the disposition.

Insider Trade Summary

Net Seller: 50,000 shares ($2,100,150)

Net Sell 2 txns

Insider Liran Ira

Role Director

Sold 50,000 shs ($2.10M)

Type	Security	Shares	Price	Value
Sale	Common Stock	50,000	$42.003	$2.10M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 692,579 shares (Indirect, by Ira Liran 2012 FT); Common Stock — 598,341 shares (Direct)

Footnotes (1)

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Ira Liran 2012 Family Trust.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liran Ira

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		S(1)		50,000	D	$42.003(2)	692,579	I	by Ira Liran 2012 FT(3)
Common Stock								598,341	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These shares are held by the Ira Liran 2012 Family Trust.

	By: Alison Klein, Attorney-in-Fact For: Ira Liran	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Liran Ira report for COCO?

He reported a sale of 50,000 shares of Vita Coco Company, Inc. common stock on 09/17/2025.

At what price were the COCO shares sold?

The weighted average price was $42.003 per share, with individual trade prices ranging from $42.00 to $42.04 as disclosed.

Was the sale part of a pre-arranged plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

How many COCO shares does the reporting person hold after the sale?

598,341 shares held directly and 692,579 shares held indirectly through the Ira Liran 2012 Family Trust, as reported.

Who signed the Form 4 filing?

By Alison Klein, Attorney-in-Fact for Ira Liran, on 09/19/2025.